Quality and Analytical Testing
What Should a Peptide Certificate of Analysis Contain?
Quick answer
A peptide certificate of analysis should identify the batch and the sequence, then report measured results for purity by HPLC, identity by mass spectrometry, water content, counter-ion content and appearance. Every result needs the method it was obtained by and the limit it was judged against. Without the accompanying chromatogram and mass spectrum, a COA is a claim rather than evidence.
Key facts at a glance
| Batch identity | Lot number, synthesis date, release date, fill quantity |
|---|---|
| Sequence data | One-letter sequence, modifications, molecular formula, theoretical mass |
| Identity result | Observed mass by ESI-MS or MALDI-TOF, method, error in Da or ppm |
| Purity result | HPLC area percent with column, gradient, wavelength and integration threshold |
| Residual content | Water by Karl Fischer, TFA or acetate counter-ion, residual solvents where relevant |
| Release | Specification limits, analyst and QA signature, storage condition and retest date |
The items a peptide COA should carry
A certificate of analysis is a release document, not a brochure. Its job is to let an independent reviewer connect one specific vial to one specific synthesis batch, and then judge that batch against limits that were set before the result was known. For a peptide, the content list is well established.
| Item | Why it matters |
|---|---|
| Batch and lot number | Links the vial to a synthesis record. Without it, the document applies to nothing in particular. |
| Sequence and modifications | The actual molecule, including disulfides, acetylation, amidation, labels and non-natural residues. |
| Molecular formula and theoretical mass | The reference value against which identity is judged. |
| Observed mass and method | ESI or MALDI result with the calculated error, so identity can be checked rather than assumed. |
| Purity by HPLC | Area percent plus column, mobile phase, gradient, wavelength, run time and integration threshold. |
| Water content | Karl Fischer result. Water is usually the largest single reason peptide content falls below purity. |
| Counter-ion content | Trifluoroacetate or acetate, measured, not estimated. It can account for a tenth of the mass. |
| Residual solvents | Relevant where dimethylformamide, dichloromethane, methanol or acetonitrile may remain. |
| Appearance | Colour and physical form of the lyophilised cake or powder. |
| Storage and retest date | Conditions under which the stated results remain valid, and the date for re-analysis. |
| Release signature | Analyst and quality reviewer, with date. A COA nobody signed has no accountable owner. |
A document that states only "purity 99%" and a molecular weight has omitted every item that makes those two figures interpretable.
Why a COA without a chromatogram cannot be verified
Every number on a COA is the output of a method, and methods differ in how much they can see. A purity of 98.2% means one thing on a 60-minute shallow gradient with a 0.05% integration threshold, and something different on a 12-minute fast gradient that discards everything below 0.5%. The chromatogram shows which case applies: whether the main peak is symmetrical, whether there is a shoulder that was integrated as part of the main peak, and whether late-eluting material was still on the column when the run ended.
The mass spectrum has the same limitation. A stated mass of 1347.7 Da may come from a deconvoluted electrospray envelope with an error of 5 ppm, or from a single low-resolution MALDI peak rounded to the nearest Dalton. Those are not equivalent evidence. When a supplier sends a one-page PDF and declines to attach the underlying chromatogram and spectrum, treat the document as a declaration of intent. A buyer who cannot inspect the raw data cannot audit the claim, and a supplier who cannot produce raw data probably did not generate it for that lot.
Purity, peptide content and mass balance are three different numbers
HPLC purity is a ratio of peak areas. It answers a narrow question: of everything that absorbed at the detection wavelength and eluted from the column, what fraction was the target peptide? It says nothing about how much of the vial, by mass, is peptide.
Peptide content is a mass fraction, and it must account for water, counter-ion, residual solvent and inorganic salts. A batch can be 97% pure by HPLC and still be 84% peptide, because the balance of the mass is water and trifluoroacetate. Buyers who compare suppliers on the HPLC figure alone are comparing a ratio with a mass fraction, which is the most common analytical mistake in peptide procurement.
Mass balance is the third number: the sum of peptide, water, counter-ion, residual solvent and inorganics should close to 100%. If it does not, something was not measured. The worked arithmetic is set out in the purity testing guide.
Identity data: theoretical mass versus observed mass
Mass spectrometry confirms that the dominant species in the vial has the mass the sequence predicts. The COA should state which mass convention was used. Monoisotopic mass, calculated from the most abundant isotope of each element, is the useful reference below roughly 2 kDa. Average mass, calculated from atomic weights, is the practical reference for larger peptides where isotope envelopes merge.
For a 1.2 kDa peptide, a tolerance of 100 ppm corresponds to about 0.12 Da, and most modern instruments reach 5 to 20 ppm on a clean sample. A reported error of 0.4 Da is not instrument noise; it is a structural question. The report should also state the ionisation mode and the charge states observed, because the deconvoluted mass is only as good as the envelope it came from. Reading that envelope is covered in how to read a peptide mass spectrum.
Water, TFA and residual solvents: the part buyers ignore
Lyophilised peptides are hygroscopic. A powder that looks dry can hold 5 to 10% water by mass, and a vial opened repeatedly in a humid room will gain more. Karl Fischer titration is the reference method and should be reported as a percentage with the sample weight. Water matters twice: it lowers peptide content per milligram, and it accelerates hydrolysis and aggregation during storage.
Trifluoroacetate is the standard ion-pairing agent in reversed-phase purification, and it stays associated with basic residues after lyophilisation. Levels of 5 to 15% w/w are common, and the counter-ion is not a contaminant in the toxicological sense, but it is mass that is not peptide. Where a sequence is intended for cell work, acetate or hydrochloride exchange may be requested. Residual solvents are governed by class limits in ICH Q3C, and acetonitrile, methanol and dichloromethane are the usual suspects in solid-phase synthesis.
Consistency checks that expose a copied COA
- Entity consistency. The company name and address on the COA, the invoice and the website should match exactly. A different address for each document is a reseller pattern.
- Lot numbering logic. Lot codes should follow a rule that can be explained. Sequential numbers shared by unrelated products suggest templated documents.
- Arithmetic. Purity plus impurities, or peptide plus water plus counter-ion, should close. Numbers copied from another batch often do not.
- Dates. A release date before the synthesis date, or a retest date generated by a fixed offset for every product, is a warning sign.
- Spectrum plausibility. An observed mass that does not match the stated sequence, or a mass reported without decimals for a 3 kDa peptide, indicates the data was not measured on that lot.
None of these checks proves fraud on its own. Together they tell you whether a follow-up question will be answered with a record or with a delay.
What MOL Changes puts on a peptide COA
MOL Changes manufactures in Changsha, China, and ships every batch with the HPLC chromatogram, the mass spectrum and the COA, so the three documents can be checked against each other. Custom synthesis runs from 5 mg to kilogram scale, with HPLC and LC-MS/MS used for release testing and HPLC purity available up to 98%+ depending on sequence length and complexity.
Our COA format states the lot, sequence, formula, theoretical and observed mass, HPLC method and area percent, water content and counter-ion where measured, storage condition and retest date. We align our documentation with ISO 9001 principles; we do not claim ISO certification, GMP certification or FDA approval, and any supplier who implies those without a certificate number and scope is worth questioning. For document requests, use contact us and quote the lot number.
Frequently asked questions
Is a peptide COA the same as a test report?
Not quite. A COA is a release statement: it lists specifications, results and a disposition for a defined lot. A test report is the raw analytical record behind it. A complete package includes both, plus the chromatogram and mass spectrum, which is why a COA alone is weaker evidence than a COA with its data attached.
What purity should a peptide COA show?
Most research-grade custom peptides are released at 95% or higher by HPLC area percent, and 98%+ is achievable for many sequences. The number is only meaningful with the method. A 98% result on a short gradient with a high integration threshold is not comparable to 95% on a long gradient that counts every minor peak.
Why does my peptide COA list a molecular weight that differs slightly from the catalogue?
The difference is usually monoisotopic versus average mass, or a counter-ion such as TFA or acetate that is included in the formula weight. Check which convention the supplier used. A genuine sequence error would shift the mass by at least one residue, typically 57 Da or more, not by a fraction of a Dalton.
Should a peptide COA include a CAS number?
Only where one exists. Many custom peptides have no CAS registry number, and a fabricated one is worse than none. For catalogue compounds a CAS number is useful for cross-checking identity, but it does not replace sequence and mass data, which are specific to the actual batch.
How long is a peptide COA valid?
The results describe the lot at release. They remain representative while the material is stored as stated and before the retest date. Once a vial is opened, or if storage conditions were breached, the COA no longer describes the material in front of you, and re-analysis is the only way to confirm it.
Can a supplier refuse to send the chromatogram?
They can, but you should treat that as an answer. A supplier who measured purity has a chromatogram file. Withholding it usually means the data is proprietary to another party, was generated on a different lot, or does not exist. Ask for the chromatogram for your lot number specifically.
Sources and scope
This answer is based on peer-reviewed peptide chemistry and analytical literature, pharmacopoeial requirements (USP <503>, Ph. Eur. 2.2.29 and 2.2.46), FDA and EMA guidance on peptide drug substances, and MOL Changes in-house synthesis and testing data. Product statements describe research-grade peptides supplied for laboratory and manufacturing use. They are not medical advice and are not a substitute for clinical judgement.
